%0 Journal Article %A Silvio Maltagliati %A Stephen Sieber %A Philippe Sarrazin %A Stéphane Cullati %A Aïna Chalabaev %A Grégoire P. Millet %A Matthieu P. Boisgontier %A Boris Cheval %T Muscle Strength Explains the Protective Effect of Physical Activity against COVID-19 Hospitalization among Adults aged 50 Years and Older %D 2021 %R 10.1101/2021.02.25.21252451 %J medRxiv %P 2021.02.25.21252451 %X Objectives Physical activity has been proposed as a protective factor for COVID-19 hospitalization. However, the mechanisms underlying this association are unclear. Here, we examined the association between physical activity and COVID-19 hospitalization and whether this relationship was explained by other risk factors for severe COVID-19.Method We used data from adults aged 50 years and older from the Survey of Health, Ageing and Retirement in Europe. The outcome was self-reported hospitalization due to COVID-19 measured before August 2020. The main exposure was usual physical activity, self-reported between 2004 and 2017. Data were analyzed using logistic regression models.Results Among the 3139 participants included in the study (69.3 ± 8.5 years, 1763 women), 266 were tested positive for COVID-19 and 66 were hospitalized. Results showed that individuals who engaged in physical activity more than once a week had lower odds of COVID-19 hospitalization than individuals who hardly ever or never engaged in physical activity (odds ratios = 0.41, 95% confidence interval = 0.22–0.74, p = .004). This association between physical activity and COVID-19 hospitalization was explained by muscle strength, but not by other risk factors.Conclusion These findings suggest that, after 50 years of age, engaging in physical activity more than once a week is associated with lower odds of COVID-19 hospitalization. The protective effect of physical activity on COVID-19 hospitalization is explained by muscle strength.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBoris Cheval is supported by an Ambizione grant (PZ00P1_180040) from the Swiss National Science Foundation (SNSF). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:SHARE (waves 1-4) was approved by the Ethics Committee of the University of Mannheim. SHARE (waves 4-7) was approved by the Ethics Council of the Max Plank Society.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe SHARE dataset is available at http://www.share-project.org/data-access.html. http://www.share-project.org/data-access.html. %U https://www.medrxiv.org/content/medrxiv/early/2021/03/01/2021.02.25.21252451.full.pdf